Decompensated heart failure in the setting of kidney dysfunction: A community-wide perspective

Nephron - Clinical Practice

Volumn 107, Issue 4, 2008, Pages

  Ismailov, Rovshan M ^a   Goldberg, Robert J ^a,b   Lessard, Darleen ^b   Spencer, Frederick A ^b,c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Heart failure; Kidney disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 38049081647     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110035     Document Type: Article

References (28)

1. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
2. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Kidney disease and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
3. Goldberg RJ, Spencer FA, Farmer C, Meyer TE, Pezzella S: Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 2005;118:728-734.
4. Goldberg RJ, Farmer C, Spencer FA, Pezzella S, Meyer TE: Use of nonpharmacologic treatment approaches in patients with heart failure. Int J Cardiol 2006;110:348-353.
5. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
6. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM: Worsening kidney function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003;9:13-25.
7. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R: Anemia and kidney disease are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-1936.
8. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of kidney disease in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689.
9. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG: Kidney disease as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 2004;44:1593-1600.
10. Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM: Kidney function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 2004;15:2195-2203.
11. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Kidney function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210.
12. Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, Burger AJ, Elkayam U: Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 2004;94:957-960.
13. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM: Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005;111:1270-1277.
14. Marenzi G, Lauri G, Guazzi M, Assanelli E, Grazi M, Famoso G, Agostoni P: Cardiac and kidney dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci 2001;321:359-366.
15. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
16. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS: The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002;40:1106-1113.
17. Smilde TD, Hillege HL, Voors AA, Dunselman PH, Van Veldhuisen DJ: Prognostic importance of kidney function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 2004;94:240-243.
18. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI: Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure. Am J Cardiol 2000;85:1110-1113.
19. Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen CO, Newman AB, Siscovick D, Psaty BM, Sarnak MJ: Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 2005;45:268-271.
20. Formiga F, Chivite D, Manito N, Casas S, Riera A, Pujol R: Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology 2006;108:73-78.
21. Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF: Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2006;17:254-261.
22. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild kidney disease. Kidney Int 1999;56:2214-2219.
23. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of kidney disease with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-562.
24. Berger AK, Duval S, Krumholz HM: Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage kidney disease and an acute myocardial infarction. J Am Coll Cardiol 2003;42:201-208.
25. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML: The association among kidney disease, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004;44:1587-1592.
26. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-570.
27. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J, Roychoudhury C, Borzak S, Fox S, Franklin M, Freundl M, Kline-Rogers E, LaLonde T, Orza M, Parrish R, Satwicz M, Smith MJ, Sobotka P, Winston S, Riba AA, Eagle KA: Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA 2002;287:1269-1276.
28. Bailey TC, Noirot LA, Blickensderfer A, et al: An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med 2007;167:586-590.